AGP Executive Report
Last update: 11 hours agoMedtech Dealmaking: Boston Scientific is back in acquisition mode, putting $1.5B into MiRus for a 34% stake and an exclusive option to buy MiRus’ Siegel balloon-expandable TAVR system—potentially adding up to $3B more if milestones are hit. Biotech Collaboration: Regeneron and Parabilis are teaming up on Helicon-based antibody-drug conjugates, with $50M upfront plus $75M equity and as much as $2.2B in milestones across multiple targets. AI + Media: Muck Rack became the first communications platform to license STAT content, aiming to give healthcare and biotech teams faster, broader monitoring as generative AI reshapes how news is found. Public Health: Boston Children’s Hospital research says the U.S. has missed key measles “eradication” checks again—suggesting measles is back in circulation. Local Business/Community: Visology is expanding across Greater Boston inside Stop & Shop stores starting Spring 2026, adding five locations. Boston Legal/Finance: Prosecutors allege a decade-long insider-trading scheme run by an ex-Goodwin Procter lawyer, with indictments unsealed in Boston.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
